IV Ketamine Therapy uses low-dose infusions administered intravenously to help reset brain pathways involved in mood regulation. This treatment targets NMDA receptors, promoting new neural growth and restoring emotional balance — often within hours or days, rather than weeks.
Each infusion lasts approximately 40–60 minutes in a calm, private room. Our medical team monitors you throughout the session to ensure safety and comfort. Most patients complete an initial six-infusion series over three weeks, with maintenance sessions as needed.
Spravato® is an FDA-approved esketamine nasal spray for adults with treatment-resistant depression. Unlike traditional medications, Spravato® acts quickly on glutamate receptors, helping restore mood stability.
When properly screened and administered with medical monitoring, ketamine therapy can be safe for many patients. We monitor you throughout your session.
Many patients begin with an initial series (often six treatments) and then move to maintenance as clinically appropriate.
Some people experience changes within days; others need multiple sessions. Individual response varies.
Spravato® is often covered for eligible patients. We can help verify benefits and guide next steps.
Conditions Treated